Hironic Q1 2026 consolidated sales up 32.5% YoY, but stock trading remains suspended

Consolidated Q1 2026 sales KRW 9,594mn (up 32.5% YoY from KRW 7,488mn), operating profit KRW 1,454mn, net income KRW 1,267mn.
Completed third-party allotment rights offering in Jan 2026 (raised KRW 13,234mn), used KRW 1,304mn to repay long-term borrowings.
Largest shareholder Lee Jin-woo's stake decreased to 16.98% (from 26.35% at year-end 2025) due to the rights offering.
Stock trading has been suspended since April 7, 2025 under KRX regulations.
Consolidated debt ratio of 11.3%, indicating a stable financial structure.
Lawsuit against Blue Core Company for invalidation of new share issuance pending (claim amount KRW 100mn).
No year-end dividend (consecutive no-dividend from 2023 to 2025).